Opaleye Management’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-65,000
Closed -$1.18M 62
2024
Q1
$1.18M Sell
65,000
-80,000
-55% -$1.18M 0.26% 46
2023
Q4
$1.44M Sell
145,000
-1,064,380
-88% -$7.82M 0.38% 40
2023
Q3
$8.13M Hold
1,209,380
2.64% 12
2023
Q2
$9.03M Buy
1,209,380
+15,380
+1% +$93.6K 2.16% 10
2023
Q1
$4.73M Buy
1,194,000
+297,400
+33% +$1.31M 1.42% 23
2022
Q4
$3.21M Buy
896,600
+775,585
+641% +$3.47M 1.12% 29
2022
Q3
$609K Buy
+121,015
New +$625K 0.25% 34

Other funds holding MOR

Opaleye Management's MOR Position: Q2 2024 in Review

Opaleye Management sold out of MorphoSys AG American Depositary Shares (MOR) in Q2 2024, closing a stake of 65,000 shares — an estimated $1.18M sold.

Opaleye Management first reported a position in MOR in Q3 2022 and held it in 7 quarters. The position peaked at $9.03M in Q2 2023. 26 funds tracked by Wall St. Rank hold MOR as of Q2 2024.

  • Opaleye Management reported no remaining MorphoSys AG American Depositary Shares position as of Q2 2024 after selling out during the quarter.
  • Opaleye Management sold 65,000 MorphoSys AG American Depositary Shares shares in Q2 2024, an estimated $1.18M.
  • Opaleye Management first reported a position in MorphoSys AG American Depositary Shares in Q3 2022 and held it in 7 quarters.
  • Opaleye Management's MorphoSys AG American Depositary Shares position peaked at $9.03M in Q2 2023.
  • 26 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q2 2024.

Based on Opaleye Management's 13F filing for Q2 2024, filed 14 Aug 2024.